Patent · US Active

Antibodies against platelet-derived growth factor (PDGF)

US9840554B2 · kind B2 · utility

1Cited by

172References

9Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Jijie Gu · Shrewsbury, US
Diana R. Bowley · Shrewsbury, US
Lucia Eaton · Grafton, US
Feng Dong · Lansdale, US
Lorenzo Benatuil · Northborough, US
Tariq Ghayur · Holliston, US
Ravi Chari · Norwich, US
Matthew Rieser · Sugar Grove, US
Anca Clabbers · Rutland, US

Key dates

Filing date	Jun 15, 2016
Grant date	Dec 12, 2017
Priority date	—
Expiry date	Jun 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Binding proteins that bind one or more of VEGF, PDGF and/or their receptors, including antibodies, CDR-grafted antibodies, humanized antibodies, binding fragments, fusion proteins, and bispecific or multispecific proteins thereof are disclosed. Also disclosed are methods of making and using the binding proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.